LACTULOSE SOLUTION- lactulose solution usp, 10 g/15 ml solution アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

lactulose solution- lactulose solution usp, 10 g/15 ml solution

kesin pharma corporation - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the prevention and treatment of portal-systemic encephalopathy, including the stages of hepatic pre-coma and coma. controlled studies have shown that lactulose solution therapy reduces the blood ammonia level by 25 to 50%; this is generally paralleled by an improvement in the patients’ mental state and by an improvement in eeg patterns. the clinical response has been observed in about 75% of patients, which is at least as satisfactory as that resulting from neomycin therapy. an increase in patients’ protein tolerance is also frequently observed with lactulose solution therapy. in the treatment of chronic portal-systemic encephalopathy, lactulose solution has been given for over 2 years in controlled studies. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

LACTULOSE solution アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

lactulose solution

cardinal health 107, llc - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

LACTULOSE solution アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

lactulose solution

cardinal health - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

Lactulose Fagron 680 mg/ml or. sol. ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lactulose fagron 680 mg/ml or. sol.

fagron belgium sa-nv - lactulose 680 mg/ml - oral solution - 680 mg/ml - lactulose 680 mg/ml - lactulose

Lactulose EG 10 g or. sol. (pwdr.) sachet ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lactulose eg 10 g or. sol. (pwdr.) sachet

eg sa-nv - lactulose 10 g - powder for oral solution - 10 g - lactulose 10000 mg - lactulose

Lactulose EG 670 mg/ml syrup ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lactulose eg 670 mg/ml syrup

eg sa-nv - lactulose 670 mg/ml - syrup - 670 mg/ml - lactulose 670 mg/ml - lactulose

Lactulose EG 670 mg/ml syrup sachet ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lactulose eg 670 mg/ml syrup sachet

eg sa-nv - lactulose 670 mg/ml - syrup - 670 mg/ml - lactulose 670 mg/ml - lactulose

Lactulose Sandoz 670 mg/ml or. sol. ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lactulose sandoz 670 mg/ml or. sol.

sandoz sa-nv - lactulose solution 670 mg/ml - oral solution - 670 mg/ml - lactulose 670 mg/ml - lactulose

Lactulose Teva 670 mg/ml or. sol. ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lactulose teva 670 mg/ml or. sol.

teva pharma belgium sa-nv - lactulose solution 670 mg/ml - oral solution - 670 mg/ml - lactulose 670 mg/ml - lactulose

Lactulose Teva 670 mg/ml or. sol. sachet ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lactulose teva 670 mg/ml or. sol. sachet

teva pharma belgium sa-nv - lactulose solution 670 mg/ml - oral solution - 670 mg/ml - lactulose 670 mg/ml - lactulose